TIP_link_300x300.jpg
$55+ Billion Stroke Management Market Size to Rise at a Stellar CAGR of 7.5% During (2022-2028) - COVID-19 Impact and Global Analysis by The Insight Partners
October 18, 2022 08:40 ET | The Insight Partners
New York, Oct. 18, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest market study on "Stroke Management Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19...
GNT Logo.png
GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)
September 19, 2022 09:00 ET | GNT Pharma Co., Ltd
Promising efficacy and safety profiles were observed in prior Phase II studies in acute ischemic stroke patients treated with recanalization therapies. The ENIS-3 trial has achieved >33% of...
Algernon Logo 1.png
Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke Study
September 12, 2022 07:00 ET | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage...
TIP_link_300x300.jpg
Non-Emergency Medical Transportation Market Size Worth $15.57Bn, Globally, by 2028 to Growing at 9.0% CAGR | Exclusive Report by The Insight Partners
August 24, 2022 05:37 ET | The Insight Partners
New York, Aug. 24, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Non-Emergency Medical Transportation Market Forecast to 2028 – COVID-19 Impact and Global...
Stroke Across America: Only 500 Miles Remain in 4,300-Cycling Journey to Raise Awareness for Stroke & Aphasia
August 18, 2022 13:15 ET | Stroke Across America
PORTOLA VALLEY, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- What do two educators, a nonprofit executive, and a former varsity soccer college athlete have in common? Brain Injury. They join the more...
factMR-logo.png
Rapid Implementation of Electrotherapy in Musculoskeletal Disorder Treatment Enhancing Efficacy of Neurorehabilitation Devices: Fact.MR
August 09, 2022 22:00 ET | FACT.MR
Seoul, South Korea, Aug. 10, 2022 (GLOBE NEWSWIRE) -- As per the latest industry analysis by Fact.MR, a market research and competitive intelligence provider, sales of neurorehabilitation devices...
Recovering From Stroke, Ex-Stanford Professor is Halfway Across America, Riding to Raise Awareness for Stroke and Aphasia
July 25, 2022 22:31 ET | Stroke Onward
PORTOLA VALLEY, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- For the past eight weeks, a team of cyclists has been pedaling its way across America, spreading awareness about stroke and the emotional...
TIP_link_300x300.jpg
Telestroke Services Market Size Worth $4.67223 Million by 2028 to Rise at a Stellar CAGR of 20.2% by 2028 | Exclusive Report By The Insight Partners
July 12, 2022 10:07 ET | The Insight Partners
New York, July 12, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Telestroke Services Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, End...
Algernon Logo 1.png
Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study
July 07, 2022 07:00 ET | Algernon Pharmaceuticals
VANCOUVER, British Columbia, July 07, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian...
Logo transparent PNG.png
PathMaker Neurosystems Receives $100,000 START Award from MassVentures
June 08, 2022 07:00 ET | PathMaker Neurosystems Inc.
BOSTON, June 08, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...